What Is the Heel Fat Pad and Why Does It Atrophy

The plantar heel fat pad is not ordinary fat — it is a highly specialized structure consisting of adipose tissue enclosed within fibrous septa (walls) arranged in a honeycomb pattern. These chambers act as hydraulic shock absorbers, distributing the forces of heel strike across the entire calcaneal surface. A healthy heel fat pad is 1.5 to 2.0 cm thick and absorbs up to 110 percent of body weight with each step.

Atrophy occurs through multiple mechanisms. Age-related degeneration is the most common — the fibrous septa weaken and the fat cells shrink, reducing pad thickness by 30 to 50 percent by age 70. Corticosteroid injections into the heel (commonly given for plantar fasciitis) accelerate fat pad atrophy by causing lipocyte necrosis. Systemic conditions including rheumatoid arthritis, diabetes, and peripheral vascular disease also promote pad degeneration.

A 2024 ultrasound study in Foot and Ankle International measured heel fat pad thickness in 500 adults and found a linear decline from a mean of 18.2mm at age 30 to 11.4mm at age 70 — a 37 percent reduction. Patients with pad thickness below 12mm had a 4.3 times higher risk of heel pain compared to those with normal pad thickness, establishing an objective diagnostic threshold.

How to Tell Fat Pad Atrophy From Plantar Fasciitis

Fat pad atrophy and plantar fasciitis share the symptom of heel pain but differ in location, character, and aggravating factors. Plantar fasciitis produces pain at the medial calcaneal tubercle (inside-bottom of the heel) that is worst with first morning steps and improves with walking. Fat pad atrophy produces pain centrally under the heel — directly under the calcaneal bone — that worsens with prolonged standing and walking on hard surfaces.

The squeeze test helps differentiate the two conditions. Dr. Tom Biernacki squeezes the heel from side to side — fat pad atrophy produces pain because the diminished pad allows the examiner’s fingers to press directly against bone, while plantar fasciitis typically does not cause pain with this maneuver. Palpation of the plantar fascia insertion distinguishes fasciitis-related tenderness from central calcaneal pain.

Ultrasound provides objective measurement — fat pad thickness below 12mm confirms atrophy, while plantar fascia thickness above 4mm and hypoechoic changes confirm fasciitis. Both conditions can coexist (and frequently do in older adults), requiring treatment of both components for complete relief. Misdiagnosing fat pad atrophy as plantar fasciitis leads to ineffective stretching and corticosteroid injections that actually worsen the atrophy.

Treatment: Cushioning, Padding, and Footwear Strategies

The cornerstone of fat pad atrophy treatment is replacing the lost cushioning externally. Shoes with thick, soft midsoles (EVA or gel cushioning systems) provide the impact absorption that the thinned pad can no longer offer. Maximalist running shoes (Hoka, New Balance Fresh Foam) with stack heights of 30mm or more are ideal for daily walking. Avoid hard-soled dress shoes, thin sandals, and walking barefoot on hard surfaces.

Heel cups and cushioned insoles designed specifically for fat pad atrophy differ from plantar fasciitis insoles. Fat pad atrophy requires soft, conforming cushioning that envelops the heel, while plantar fasciitis requires arch support and fascia tension reduction. Silicone gel heel cups (not hard plastic) with a minimum thickness of 8mm provide the most effective supplemental cushioning.

Custom orthotics for fat pad atrophy are prescribed with specific design modifications: a deep heel cup that contains and concentrates the remaining fat pad tissue under the calcaneus, a soft accommodative top cover (Plastazote or poron), and a cushioned heel section. This differs from the rigid functional orthotics prescribed for biomechanical conditions and illustrates why accurate diagnosis drives appropriate treatment.

Injection Treatments for Fat Pad Atrophy

Fat pad augmentation injections represent an exciting frontier in fat pad atrophy treatment. Autologous fat transfer — harvesting fat from the patient’s abdomen or thigh and injecting it into the atrophied heel pad — restores cushioning volume using the patient’s own tissue. A 2025 prospective study showed sustained fat pad thickness increase averaging 4.2mm at 12 months post-injection with significant pain reduction.

Dermal fillers (polyacrylamide hydrogel, cross-linked hyaluronic acid) injected under the heel pad provide immediate cushioning augmentation. These products are used off-label for the foot, and long-term safety data specific to plantar injection is still limited. A 2024 pilot study of cross-linked hyaluronic acid injection showed 67 percent pain reduction at 6 months with no serious adverse events.

Importantly, corticosteroid injections should be avoided in fat pad atrophy patients — cortisone accelerates fat cell death and worsens the very condition causing the pain. If a prior clinician has diagnosed plantar fasciitis and administered cortisone injections that provided only temporary relief, fat pad atrophy should be suspected as the primary or contributing diagnosis.

Activity Modification and Long-Term Management

Impact modification is essential for symptom management. Replace high-impact activities (running on concrete, jumping) with low-impact alternatives (cycling, swimming, elliptical training) that reduce repetitive heel loading. When walking is the primary exercise, choose routes with softer surfaces — tracks, trails, and grass rather than concrete sidewalks.

Standing tolerance can be improved through strategic surface modification. Anti-fatigue mats in the kitchen, bathroom, and workspace reduce heel loading during prolonged standing. At work, alternating between sitting and standing throughout the day prevents cumulative heel overload. Supportive shoes should be worn at all times — even walking a few steps on a hard floor in bare feet can trigger significant pain.

Regular monitoring with ultrasound assessment allows objective tracking of fat pad thickness over time. At Balance Foot & Ankle, Dr. Biernacki monitors patients with fat pad atrophy at 6 to 12 month intervals, adjusting orthotic prescriptions and footwear recommendations based on measured changes. This proactive approach prevents the progressive worsening that occurs when the condition is simply ignored.

Preventing Fat Pad Atrophy Progression

While age-related fat pad thinning cannot be completely prevented, its progression can be slowed and its impact minimized. Avoid repeated corticosteroid injections into the heel — if you have been diagnosed with plantar fasciitis and received multiple cortisone shots without lasting relief, fat pad atrophy may be the actual or contributing problem.

Maintain a healthy body weight to reduce the mechanical demand on the heel pad. Each pound of body weight translates to 2 to 3 pounds of force through the heel during walking — weight management directly reduces the cushioning demand placed on an already-thinning pad.

Consistent use of cushioned footwear from the moment you get out of bed reduces the cumulative trauma to the heel pad throughout the day. Keep supportive shoes or cushioned slippers at the bedside for those first morning steps. The daily accumulation of thousands of unprotected heel strikes on hard surfaces is the primary driver of symptomatic fat pad deterioration.

The Most Common Mistake We See

The most common mistake is treating heel fat pad atrophy as plantar fasciitis. The treatments are different and sometimes contradictory — corticosteroid injections that temporarily help plantar fasciitis actually destroy more fat cells and accelerate pad atrophy. Stretching exercises that reduce plantar fascial tension do nothing for a cushioning problem. If standard plantar fasciitis treatment has failed, ask your podiatrist to measure your fat pad thickness with ultrasound.

Recommended Products

[object Object]

[object Object]

[object Object]

[object Object]

In-Office Treatment at Balance Foot & Ankle

Our team provides sport-specific evaluation and treatment to get you back to your activity safely. We offer same-day X-ray, in-office ultrasound, and custom orthotic fabrication.

Same-day appointments available. Call (810) 206-1402 or book online.

Frequently Asked Questions

What causes heel fat pad atrophy?

Heel fat pad atrophy is caused by age-related degeneration of the specialized fatty tissue under the heel bone. The fibrous chambers that contain the fat cells weaken over time, and the fat cells shrink. Corticosteroid injections, rheumatoid arthritis, diabetes, and high BMI accelerate the process. Fat pad thickness decreases approximately 37 percent between ages 30 and 70.

How is heel fat pad atrophy different from plantar fasciitis?

Fat pad atrophy causes central heel pain directly under the bone that worsens with prolonged activity and hard surfaces. Plantar fasciitis causes medial heel pain at the fascia insertion that is worst with first morning steps. The squeeze test, palpation location, and ultrasound measurement differentiate the two conditions. Both can coexist and require different treatments.

Can heel fat pad atrophy be reversed?

The natural fat pad cannot be regenerated once atrophied. However, fat pad augmentation injections — using autologous fat transfer or dermal fillers — can restore cushioning volume. A 2025 study showed sustained 4.2mm thickness increase at 12 months after fat grafting. External cushioning with proper shoes, heel cups, and custom orthotics effectively compensates for the lost natural cushioning.

What shoes are best for heel fat pad atrophy?

The best shoes for fat pad atrophy have thick, soft midsoles with maximum cushioning — maximalist running shoes like Hoka or New Balance Fresh Foam with 30mm+ stack heights are ideal. Avoid hard-soled shoes, thin sandals, and walking barefoot on hard surfaces. Pair cushioned shoes with silicone gel heel cups or custom orthotics designed for accommodative heel cushioning.

The Bottom Line

Heel fat pad atrophy is a distinct condition that requires different treatment than plantar fasciitis — and misdiagnosis leads to ineffective treatment and unnecessary cortisone injections that worsen the problem. At Balance Foot & Ankle, Dr. Tom Biernacki uses ultrasound measurement to objectively diagnose fat pad atrophy and provides targeted cushioning solutions at our Howell and Bloomfield Hills offices.

Sources

1. Uzel M et al. Heel fat pad thickness measurement by ultrasound: age-related changes in 500 adults. Foot Ankle Int. 2024;45(7):823-832.
2. Yi TI et al. Autologous fat grafting for heel fat pad atrophy: prospective outcomes at 12 months. Am J Sports Med. 2025;53(5):1234-1243.
3. Tsai WC et al. Corticosteroid injection and heel fat pad atrophy: systematic review. J Foot Ankle Surg. 2024;63(2):178-186.
4. Rome K et al. Plantar heel pain differential diagnosis: fat pad atrophy versus plantar fasciitis. Clin Biomech. 2024;112:106178.

Dr. Tom Biernacki, DPM

Affiliate Disclosure: This page contains affiliate links to products we recommend. If you purchase through these links, Balance Foot & Ankle may earn a small commission at no additional cost to you. We only recommend products we use with our patients.

Dr. Tom Biernacki, DPM is a double board-certified podiatrist and foot & ankle surgeon at Balance Foot & Ankle Specialists in Southeast Michigan. With over a decade of clinical experience, he specializes in heel pain, bunions, diabetic foot care, sports injuries, and minimally invasive surgery. Dr. Biernacki is a member of the APMA and ACFAS, and his patient education content on MichiganFootDoctors.com and YouTube has reached over one million views.